AstraZeneca's Indian unit is planning to sell its 64-acre manufacturing facility in North Bengaluru for an estimated ₹3,400 crore. The move is part of a global review of its manufacturing network and a broader land monetization strategy. Developers like Sattva Group, Aurobindo Pharma, and RMZ have shown interest in the prime land parcel.
from Top Real Estate News | Latest Realty & Real Estate Industry Information and Updates: ET Realty : ETRealty.com https://ift.tt/ocHKQUa
via IFTTT
Subscribe to:
Post Comments (Atom)
-
Searching for a dynamic and well-connected space to establish your business in Gurgaon? Look no further than Satya The Hive in Sector 102 ...
-
When it comes to finding a perfect residential project blend of luxury and convenience in Gurgaon, Ganga Realty Anantam sec 85 Gurgaon stan...
-
Prime Location for Business Growth: Are you searching for a prime location to establish or expand your business in Gurgaon? Look no further ...
No comments:
Post a Comment